The Patent Finder

Standard Chem. & Pharm. Co., Ltd.

Also on record
Records under this name other than patents Standard Chem. & Pharm. Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Standard Chem. & Pharm. Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,557,784Glycyrrhizinates of morphinan derivatives
Lapsed on the fee record
Ended Oct 15, 2021 · USPTO record
Lapsed on the fee recordEnded Oct 15, 2021USPTO record
US 8,202,995Pharmaceutically acceptable salts of aporphine derivatives and carboxyl group-containing agents and methods for preparing the same
Lapsed on the fee record
Ended Jun 19, 2020 · USPTO record
Lapsed on the fee recordEnded Jun 19, 2020USPTO record
US 8,093,260Aporphine derivatives and pharmaceutical use thereof
Lapsed on the fee record
Ended Jan 10, 2020 · USPTO record
Lapsed on the fee recordEnded Jan 10, 2020USPTO record
US 6,726,931Process for preparing oral sustained-release formulation of felodipine
Lapsed on the fee record
Ended Apr 27, 2016 · USPTO record
Lapsed on the fee recordEnded Apr 27, 2016USPTO record
US 6,346,269Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
Lapsed on the fee record
Ended Feb 12, 2010 · USPTO record
Lapsed on the fee recordEnded Feb 12, 2010USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited